Browsing by Author "Tatli, V"

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    The Analysis of The Efficacy and Safety of Transobturator Sling Operation by Using an Adjustable Sling Device in The Treatment of Stress Urinary Incontinence
    Temeltas, G; Yuksel, MB; Tatli, V; Gumus, B
    Objectives: We aimed to evaluate the safety and efficacy of a transobturator sling (TOT) procedure by using an adjustable TOT device in the treatment of stress urinary incontinence (SUI). Materials and Methods: The data of 89 patients who had the diagnosis of SUI and underwent TOT operation by using an adjustable MUS device of SAFYRE t plus (Promedon (R)) between June 2005 - November 2012, were retrospectively evaluated. The pateints were evaluted by the parametres of physical examination, stress test, ultrasonography, uroflowmetry, residual urine measurement, cystometry, subjective incontinence scoring (VASi), patients' satisfaction scoring (VASs), and ICQ-SF questionare. The preoperative, perioperative, and postoperative collected data were statistically analysed to determine the efficacy and safety of TOT application by using SAFYRE t plus. Results: The mean age, account of parity, and body mass index was 55.3 +/- 10.1, 2.34 +/- 1.43, and 24.97 +/- 3.7, respectively. While the pre- and postoperative results of stress test, VASi, and ICIQ-SF scores were significantly different (P=0.00 in all), the pre- and postoperative results of Qmax and PVR account were similar (P = 0.84, P = 0.79, respectively). The severity of subjective incontinence (VASi score) significantly improved after the operation. The mean VASs score at postoperative 12th month was 7.75 +/- 1.11. The subjective and objective cure rates were % 89.9 (80/89) and % 78.6 (70/89), respectively. Conclusion: The TOT operation by using SAFYRE t plus, which was an adjustable sling device, seemed to be an efficient, reasonably safe, minimally invasive treatment alternative for the surgical management SUI in women.
  • No Thumbnail Available
    Item
    The long-term results of temporary urethral stent placement for the treatment of recurrent bulbar urethral stricture disease
    Temeltas, G; Ucer, O; Yuksel, MB; Gumus, B; Tatli, V; Muezzinoglu, T
    Aim: To evaluate the long term outcomes of temporary urethral stent placement for the treatment of recurrent bulbar urethral stricture. Materials and Methods: Twenty-eight patients who underwent temporary polymer coated urethral stent placement due to recurrent bulbar urethral stricture between 2010 and 2014 were enrolled in the study. The long term outcomes of the patients were analyzed. Results: The mean age of the patients was 62.3 +/- 6.4 (44-81). The overall clinical success was achieved in 18 (64.2%) of the 28 patients at a median (range) follow-up of 29 (7-46) months. No patient reported discomfort at the stent site. Stone formation was observed at the urethral stent implantation area only in one patient. Stenosis occurred in the distal end of the stents in two patients and took place in bulbar urethra in seven patients after removed the stents. The mean maximum urine flow rates were 6.24 +/- 2.81mL/sec and 19.12 +/- 4.31mL/sec before and at 3 months after the procedure, respectively. Conclusion: In this study, the success rate of temporary urethral stent placement has remained at 64.2% at a median follow-up of 29 months. Therefore, our outcomes have not achieved desired success rate for the standard treatment of recurrent bulbar urethral stricture.
  • No Thumbnail Available
    Item
    What is the Color of Cancer?
    Tatli, V; Üçer, O; Müezzinoglu, T
    Objective: To investigate the colors that evokes cancer in the patients with prostate, lung and breast cancer, and in healthy controls. Materials and Methods: A visual card in one of the 9 colors (white, red, orange, yellow, green, blue, purple, navy, black) was shown to totally 210 patients diagnosed with lung cancer (LC), prostate cancer (PC) or breast cancer (BC) and 200 healthy participants and the question of What is the color of cancer? was asked to them. Disease information of the cancer patients were also recorded. Results: The mean ages of the patient and control groups were 61.54 and 20.49, respectively (p<0.001). While the most preferred color was yellow (24.8%) in the patient group, it was red (39%) in the control group. The patients were divided into three groups according to both type and stage of cancer. While the patients with PC and BC selected yellow color, the patients with LC selected black color. The patients without recurrent and residual diseases preferred yellow, patients with local recurrence preferred red and patients with distant metastasis preferred black colors. Conclusion: While cancer patients selected yellow color which represents positive emotions, the healthy young individuals selected red color which represents negative emotions. However, progressive or aggressive cancer patients selected red and black colors which is associated with negative emotions.